Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier.
Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier.
复制标题
DOI:
10.1002/ijc.24725
复制
发表时间:
2010-01-15
影响因子:
6.4
通讯作者:
Raucher, Drazen
中科院分区:
文献类型:
--
作者:
Massodi, Iqbal;Moktan, Shama;Rawat, Aruna;Bidwell, Gene L., III;Raucher, Drazen
Current treatment of solid tumors is limited by normal tissue tolerance, resulting in a narrow therapeutic index. To increase drug specificity and efficacy and to reduce toxicity in normal tissues, we have developed a polypeptide carrier for a cell cycle inhibitory peptide, which has the potential to be thermally targeted to the tumor site. The design of this polypeptide is based on elastin-like polypeptide (ELP). The coding sequence of ELP was modified by the addition of the cell penetrating peptide Bac-7 at the N-terminus and a 23 amino acid peptide derived from p21 at the C-terminus (Bac-ELP1-p21). Bac-ELP1-p21 is soluble in aqueous solutions below physiological temperature (37°C) but aggregates when the temperature is raised above 39°C, making it a promising thermally responsive therapeutic carrier that may be actively targeted to solid tumors by application of focused hyperthermia. While Bac-ELP1-p21 at 37°C did not have any effect on SKOV-3 cell proliferation, the use of hyperthermia increased the antiproliferative effect of Bac-ELP1-p21 compared with a thermally unresponsive control polypeptide. Bac-ELP1-p21 displayed both a cytoplasmic and nuclear distribution in the SKOV-3 cells, with nuclear-localized polypeptide enriched in the heated cells, as revealed by confocal microscopy. Using Western blotting, we show that Bac-ELP1-p21 caused a decrease in Rb phosphorylation levels in cells treated at 42°C. The polypeptide also induced caspase activation, PARP cleavage, and cell cycle arrest in S-phase and G2/M-phase. These studies indicate that ELP is a promising macromolecular carrier for the delivery of cell cycle inhibitory peptides to solid tumors.
登录
查看更多内容
影响因子:
64.8
作者:
LUO, Y;HURWITZ, J;MASSAGUE, J
通讯作者:
MASSAGUE, J
影响因子:
5.8
作者:
Bidwell, GL;Raucher, D
通讯作者:
Raucher, D
影响因子:
5.8
作者:
Bidwell, Gene L., III;Fokt, Izabela;Raucher, Drazen
通讯作者:
Raucher, Drazen
影响因子:
10.8
作者:
Massodi, I;Bidwell, GL;Raucher, D
通讯作者:
Raucher, D
影响因子:
3.4
作者:
Bidwell, Gene L., III;Davis, Aisha N.;Raucher, Drazen
通讯作者:
Raucher, Drazen